Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease

Anna Parfieniuk, Robert Flisiak, Role of cannabinoids in chronic liver diseases. World Journal of Gastroenterology. ,vol. 14, pp. 6109- 6114 ,(2008) , 10.3748/WJG.14.6109

Robert Charles Ladner, Robert Earl Bird, Single polypeptide chain binding molecules ,(1987)

Vanessa Deveaux, Thomas Cadoudal, Yasukatsu Ichigotani, Fatima Teixeira-Clerc, Alexandre Louvet, Sylvie Manin, Jeanne Tran-Van Nhieu, Marie Pierre Belot, Andreas Zimmer, Patrick Even, Patrice D. Cani, Claude Knauf, Remy Burcelin, Adeline Bertola, Yannick Le Marchand-Brustel, Philippe Gual, Ariane Mallat, Sophie Lotersztajn, Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis PLoS ONE. ,vol. 4, pp. e5844- ,(2009) , 10.1371/JOURNAL.PONE.0005844

Doree F. Sitkoff, Taekyu Lee, Chongqing Sun, William R. Ewing, Yanting Huang, Bicyclic heterocycles as cannabinoid receptor modulators ,(2006)

Raphael Mechoulam, Susanna Tchilibon, Lumir Hanus, Ester Fride, Aviva Breuer, Michal Horowitz, Aaron Garzon, Agonists specific for the peripheral cannabinoid receptor ,(2000)

Gregory P. Winter, Recombinant altered antibodies and methods of making altered antibodies ,(1991)

Michael Alan Boss, Clive Ross Wood, John Henry Kenten, John Spencer Emtage, Multichain polypeptides or proteins and processes for their production ,(1984)

Kary Banks Mullis, Process for amplifying nucleic acid sequences ,(1986)

Paul M. Lizardi, Rolling circle replication reporter systems ,(1998)

Akira Ohhata, Mikio Ogawa, Yoshikazu Takaoka, 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient ,(2001)